We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Marina Biotech Publishes Pre-Clinical Research on RNAi-Based Therapeutics Targeting Survivin and PLK1 in Bladder Cancer

Product News   Mar 04, 2011

 
Marina Biotech Publishes Pre-Clinical Research on RNAi-Based Therapeutics Targeting Survivin and PLK1 in Bladder Cancer
FURTHER INFORMATION
 
 
 

Related Product News

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Custom, Sustainable Lyophilized Products

Product News

Integrated DNA Technologies has partnered with Argonaut Manufacturing Services to provide custom, environmentally-friendly lyophilized reagents.

READ MORE

Advancing Automation With the S-LAB Plate Handler

Product News

Peak Analysis & Automation (PAA) has released a series of new application notes demonstrating its benchtop S-LAB™ automated plate handler.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE